Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Net Margin Over TimeExpanding
Percentile Rank80
Studio
Year-over-Year Change

Net income as a percentage of revenue

Latest
-14.72%
↑ 92% vs avg
Percentile
P80
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
-186.92%
Historical baseline
PeriodValueYoY Change
TTM-14.72%+76.7%
2024-63.16%+91.9%
2023-778.89%-223.8%
2022-240.51%-892.0%
2021-24.25%-
20200.00%-